# ğŸ“… Daily Report - 2025-11-02

> ä»Šæ—¥ç­›é€‰å‡º **14** æ¡å†…å®¹ï¼Œæ¥è‡ª **4** ä¸ªæ¥æº

<div class="powered-by-top">Powered by <a href="https://kyplus.de">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai">Claude</a></div>

---

## ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“

### ğŸ“° å…¬ä¼—å·

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
é¦–æ¬¡è¯å®èƒ°è…ºç™Œä¸­å­˜åœ¨æ„Ÿå®˜ç¥ç»å…ƒä¸ç™Œç»†èƒçš„â€œå‡æ€§çªè§¦â€ï¼Œé©±åŠ¨è‚¿ç˜¤è¿›å±•ï¼›å•ç»†èƒç©ºé—´è½¬å½•ç»„æ­ç¤ºå¤šå‘æ€§ç¡¬åŒ–ç—…ç¶çš„è‡´ç—…æ€§å…ç–«ç»†èƒå¾®ç¯å¢ƒã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- ç¥ç»-è‚¿ç˜¤äº’ä½œï¼šæ³›ç™Œåˆ†ææ­ç¤ºæ˜Ÿçº§çƒ­ç‚¹äº’ä½œã€‚
- ç™Œç—‡å¾®ç¯å¢ƒï¼šæ¢ç´¢å·¨å™¬ç»†èƒå¤šæ ·æ€§åŠå…¶åœ¨ç™Œç—‡ä¸­çš„ä½œç”¨ã€‚
- ç¥ç»ç³»ç»Ÿç–¾ç—…ï¼šè§£æå¤šå‘æ€§ç¡¬åŒ–ç—…ç¶çš„å…ç–«ç»†èƒå¾®ç¯å¢ƒã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- **Nicheformer**ï¼šå°†ç©ºé—´å¾®ç¯å¢ƒä¿¡æ¯æ•´åˆè‡³å•ç»†èƒå¤§æ¨¡å‹ã€‚
- **CellCharter**ï¼šä¸€ç§é«˜æ•ˆçš„ç©ºé—´èšç±»åˆ†æç®—æ³•ã€‚

### ğŸ§¬ æ•°æ®å‰æ²¿

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
ç ”ç©¶æ­ç¤ºäº†KRASæŠ‘åˆ¶å‰‚è€è¯æ€§ä¸ç»“ç›´è‚ ç™Œä¸­å¢å¼ºå­é‡å¡‘ä»‹å¯¼çš„ç”²ç¾ŸæˆŠé…¸é€šè·¯æ¿€æ´»å¯†åˆ‡ç›¸å…³ï¼Œä¸ºå…‹æœè€è¯æä¾›äº†æ–°é¶ç‚¹ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
*   **è‚¿ç˜¤è€è¯æœºåˆ¶**ï¼šè§£æKRASæŠ‘åˆ¶å‰‚åœ¨ç»“ç›´è‚ ç™Œä¸­çš„è€è¯æœºåˆ¶ã€‚
*   **RNAå›¾è°±ç»˜åˆ¶**ï¼šæ„å»ºå°é¼ 19ä¸ªç»„ç»‡ä¸­ tRNAã€tRNAè¡ç”Ÿçš„çŸ­RNAåŠå…¶ä¿®é¥°è°±çš„é«˜åˆ†è¾¨ç‡å›¾è°±ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
*   **é«˜é€šé‡æµ‹åº**ï¼šåˆ©ç”¨é«˜é€šé‡æµ‹åºæŠ€æœ¯è¿›è¡ŒåŸºå› ç»„ç»“åˆ/å æ®è°±åˆ†æå’Œè¡¨è¾¾è°±åˆ†æã€‚
*   **éç¼–ç RNAè°±åˆ†æ**ï¼šé€šè¿‡é«˜é€šé‡æµ‹åºæŠ€æœ¯è¿›è¡Œéç¼–ç RNAè°±åˆ†æï¼Œè§£æ tRNA åŠå…¶è¡ç”Ÿç‰©ã€‚

### ğŸ”¬ æœŸåˆŠæ–‡ç« 

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
å…ç–«åŸæ€§ç»†èƒæ­»äº¡ï¼ˆICDï¼‰é€šè¿‡é‡Šæ”¾DAMPsé‡å¡‘è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒï¼ˆTIMEï¼‰ï¼Œä¸ºç™Œç—‡æ²»ç–—æä¾›äº†æ–°çš„é¶å‘ç­–ç•¥ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- æ¢ç´¢è°ƒèŠ‚æ€§ç»†èƒæ­»äº¡ï¼ˆRCDï¼‰ä¸å…ç–«æ¿€æ´»çš„ç›¸äº’ä½œç”¨ï¼Œä»¥é‡æ–°è¿æ¥è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒã€‚
- é‡æ–°æ€è€ƒè‚¿ç˜¤å­¦è¯•éªŒçš„ç»ˆç‚¹ï¼Œè¶…è¶Šä¼ ç»Ÿçš„På€¼ç»Ÿè®¡æ–¹æ³•ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- åˆ©ç”¨ICDè¯±å¯¼è‚¿ç˜¤ç»†èƒæ­»äº¡å¹¶é‡Šæ”¾ä¿¡å·åˆ†å­ï¼Œæ¿€æ´»æŠ—è‚¿ç˜¤å…ç–«ååº”ã€‚

### ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
æå‡Shinyåº”ç”¨æµ‹è¯•çš„æ•ˆç‡å’Œå¥å£®æ€§ï¼Œé€šè¿‡ç›´æ¥è°ƒç”¨JavaScript APIç®€åŒ–å¤æ‚ç»„ä»¶çš„äº¤äº’æµ‹è¯•ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- é’ˆå¯¹Shiny `shinytest2` æ¡†æ¶ä¸­ `set_inputs()` æ–¹æ³•éš¾ä»¥åº”å¯¹çš„å¤æ‚ç»„ä»¶äº¤äº’ã€‚
- å¼€å‘æ›´ç®€æ´ã€å¿«é€Ÿã€å¯é çš„Shinyåº”ç”¨è‡ªåŠ¨åŒ–æµ‹è¯•è„šæœ¬ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- ç›´æ¥åˆ©ç”¨JavaScript APIç»•è¿‡`set_inputs()`çš„å±€é™ï¼Œå®ç°å¯¹å¤æ‚Shinyç»„ä»¶çš„ç²¾ç»†åŒ–æ§åˆ¶ã€‚

---

## ğŸ“š åˆ†ç±»æµè§ˆ

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (8æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨8æ¡ï¼‰

**1.** â­ **å†¯è‹¥è½»/åˆ˜ç’ç­‰Immunityï¼šé€šè¿‡å•ç»†èƒç©ºé—´è½¬å½•ç»„å‘ç°å¤šå‘æ€§ç¡¬åŒ–ç—…ç¶çš„è‡´ç—…æ€§ç‚ç—‡å…ç–«ç»†èƒå¾®ç¯å¢ƒ**
- âœï¸ **ä½œè€…**ï¼šCellPresså…¨ç§‘å­¦
- ğŸ·ï¸ **å…³é”®è¯**ï¼šå•ç»†èƒã€ç©ºé—´è½¬å½•ç»„ã€è½¬å½•ç»„
- ğŸ“ **æè¿°**ï¼šè¯¥ç ”ç©¶åœ¨äººç±»æ…¢æ€§æ´»åŠ¨æ€§ç—…ç¶ä¸­æç»˜å‡ºå•ç»†èƒåˆ†è¾¨ç‡çš„ç©ºé—´å›¾è°±ã€‚
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&mid=2247656590&idx=2&sn=a641764a2dbdf4a67e3663583a8ca7c5)

**2.** **10æœˆæœ€æ–°çº¯ç”Ÿä¿¡ï¼Œèšç„¦æ˜Ÿçº§çƒ­ç‚¹ç¥ç»-è‚¿ç˜¤äº’ä½œçš„å¤šç»„å­¦æ³›ç™Œåˆ†æï¼Œå¿«æ¥æ¬£èµä¸€ä¸‹ï¼**
- âœï¸ **ä½œè€…**ï¼šä¸œæ™“ç”Ÿç‰©
- ğŸ·ï¸ **å…³é”®è¯**ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&mid=2247492976&idx=1&sn=4845a62c26023dcb31fd3ca19c8ec1ba)

**3.** **Cancer Cellfå‘è¡¨ï¼šæ„Ÿå®˜ç¥ç»å…ƒé€šè¿‡è°·æ°¨é…¸èƒ½ç¥ç»å…ƒ - ç™Œç—‡ä¼ªçªè§¦é©±åŠ¨èƒ°è…ºç™Œè¿›å±•**
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡å°è¯¾å ‚
- ğŸ·ï¸ **å…³é”®è¯**ï¼šç™Œç—‡ã€cancer
- ğŸ“ **æè¿°**ï¼šæœ€æ–°Cancer Cellé‡ç£…ï¼Œèƒ°è…ºç™Œä¸­é¦–æ¬¡è¯å®ç¥ç»å…ƒä¸ç™Œç»†èƒé—´å­˜åœ¨ â€œç¥ç»å…ƒ-ç™Œç»†èƒå‡æ€§çªè§¦â€ï¼Œå¹¶å½¢æˆæ­£åé¦ˆå¢å¼ºè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ï¼
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&mid=2247503784&idx=1&sn=aa351f1f244fbeb32400f1d38f30cf44)

**4.** **ç»¼è¿° | TrendsCancer | æ‹¥æŠ±å¤šæ ·æ€§ï¼šç™Œç—‡ä¸­å·¨å™¬ç»†èƒçš„å¤æ‚æ€§**
- âœï¸ **ä½œè€…**ï¼šBioJournal Link
- ğŸ·ï¸ **å…³é”®è¯**ï¼šç™Œç—‡ã€cancer
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&mid=2247502192&idx=1&sn=afa0e16ec5808e8588904eea7095c62e)

**5.** **ç©ºé—´èšç±»åˆ†æä¹‹cellcharter**
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡èœé¸Ÿå›¢
- ğŸ·ï¸ **å…³é”®è¯**ï¼šèšç±»
- ğŸ“ **æè¿°**ï¼šæœ¬æœŸå°†ç»§ç»­å¸¦å¤§å®¶äº†è§£å¦ä¸€æ¬¾å‘è¡¨åœ¨ Nature Genetics ä¸Šçš„é«˜åˆ†ç©ºé—´èšç±»ç®—æ³•CellCharterã€‚
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=MzUzMTEwODk0Ng==&mid=2247537834&idx=1&sn=098168f9161fab2a625eae1e91cb57c4)

**6.** **Nat Methods| Nicheformerï¼šæŠŠâ€œç©ºé—´å¾®ç¯å¢ƒâ€è£…è¿›å•ç»†èƒçš„å¤§æ¨¡å‹é‡Œ**
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡å°åšå£«
- ğŸ·ï¸ **å…³é”®è¯**ï¼šå•ç»†èƒ
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg2NDcxMzYwNg==&mid=2247490292&idx=1&sn=4a00f8eee445039385881831605aef68)

**7.** **ç®€åŒ–GWASæµç¨‹ï¼SNPRelateåŒ…ï¼Œé—ä¼ ä¿¡æ¯çš„ç²¾å‡†ç¿»è¯‘å®˜ï¼**
- âœï¸ **ä½œè€…**ï¼šäº‘ç”Ÿä¿¡
- ğŸ·ï¸ **å…³é”®è¯**ï¼šRåŒ…
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&mid=2247498380&idx=1&sn=939ff40b5a0bb09662d944c83b73f5d8)

**8.** **èƒ½æŠŠè¿™ç¯‡Natureçš„å•ç»†èƒä»£ç å­¦æ˜ç™½ï¼Œå…ç–«ç»†èƒçš„åˆ†æä»¥åå°±ä¸æ„äº†**
- âœï¸ **ä½œè€…**ï¼šç”Ÿä¿¡é’±åŒå­¦
- ğŸ·ï¸ **å…³é”®è¯**ï¼šå•ç»†èƒ
- ğŸ“ **æè¿°**ï¼šå•ç»†èƒä»£ç ç»å…¸æ–‡ç« 
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&mid=2247495384&idx=1&sn=dda01e3432f1b56915a3ce2800b5d8c3)


</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (2æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰

**1.** â­ **GSE306909 Enhancer Remodeling-Driven Mevalonate Pathway Confers Resistance to KRAS Inhibitor in Colorectal Cancer**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€Scanpyã€histoneã€pathway
- ğŸ“ **æè¿°**ï¼šContributors : Yaoyu Guo ; J TanSeries Type : Genome binding/occupancy profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Homo sapiensThis study investigates the resistance mechanisms to pan-KRAS inhibitors in colorectal cancer (CRC). We established a panel of patient-derived organoids (PDOs) and cell lines with differential sensitivity to pan-KRAS inhibitors. Integrated epigenomic (ChIP-seq for H3K27ac and H3K4me3) and transcriptomic (RNA-seq)...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306909)

**2.** â­ **GSE309058 An isodecoderâ€‘resolved map of mouse tRNAs, tRNAâ€‘derived small RNAs, and RNA modification signatures across 19 tissues**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€Seuratã€clustering
- ğŸ“ **æè¿°**ï¼šContributors : Aidan C Manning ; Todd M Lowe ; Patricia P ChanSeries Type : Non-coding RNA profiling by high throughput sequencingOrganism : Mus musculusTransfer RNAs (tRNAs) and their derived small RNAs (tDRs) vary across mammalian tissues, but the . We applied Ordered Two-Template Relay sequencing (OTTR-seq) to profile small RNAs in 19 tissues from adult mice, quantifying mature tRNAs and tDRs at isodecoder resolution and inferring select baseâ€‘modification signatures from reverseâ€‘transcriptase...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309058)


</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (3æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰

**1.** **ç™Œç—‡ä¸­ç»†èƒæ­»äº¡å…ç–«ä¸²æ‰°çš„æ²»ç–—é¶å‘ä»¥é‡æ–°è¿æ¥è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒ**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šè‚¿ç˜¤ã€ç™Œç—‡
- ğŸ“ **æè¿°**ï¼šSecret hovertext: å…ç–«ç³»ç»Ÿé€šè¿‡åè°ƒæŠ‘åˆ¶æ¶æ€§è‚¿ç˜¤çš„å‘ç”Ÿã€è¿›å±•å’Œè½¬ç§»çš„æŠ—è‚¿ç˜¤ååº”ï¼Œåœ¨æŠ—ç™Œé˜²å¾¡ä¸­å‘æŒ¥æ ¸å¿ƒä½œç”¨ã€‚æ–°å‡ºç°çš„è¯æ®å¼ºè°ƒäº†è°ƒèŠ‚ç»†èƒæ­»äº¡ ï¼ˆRCDï¼‰ é€”å¾„ä¸å…ç–«æ¿€æ´»ï¼ˆç‰¹åˆ«æ˜¯å…ç–«åŸæ€§ç»†èƒæ­»äº¡ ï¼ˆICDï¼‰ï¼‰ä¹‹é—´è‡³å…³é‡è¦çš„ç›¸äº’ä½œç”¨ã€‚ICD æ˜¯æŒ‡è‚¿ç˜¤ç»†èƒæ­»äº¡å¹¶é‡Šæ”¾æŸä¼¤ç›¸å…³åˆ†å­æ¨¡å¼ï¼ˆDAMPï¼‰å’Œå…¶ä»–ä¿¡å·åˆ†å­ï¼Œä»è€Œé‡å¡‘è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒï¼ˆTIMEï¼‰çš„ä¸€ç§ç‰¹å®šå½¢å¼çš„è°ƒèŠ‚æ€§ç»†èƒæ­»äº¡ã€‚è™½ç„¶è§„èŒƒçš„ RCD é€”å¾„å·²ç»å¾ˆæˆç†Ÿï¼Œä½† ICD çš„è¯±å¯¼å› å­ã€TIME åŠ¨åŠ›å­¦çš„æ—¶ç©ºè°ƒèŠ‚ä»¥åŠå…ç–«ç»†èƒçš„åŠŸèƒ½çŠ¶æ€ä»ä¸å®Œå…¨æ¸…æ¥šã€‚æˆ‘ä»¬å½»åº•è¯„ä¼°äº†åˆ©ç”¨ RCD é©±åŠ¨çš„å…ç–«è°ƒèŠ‚ä½œç”¨æœºåˆ¶çš„å½“ä»£æ²»ç–—æ–¹æ³•ï¼ŒåŒ…æ‹¬å¢å¼º ICD å’Œå¢å¼ºæŠ—è‚¿ç˜¤å…ç–«ååº”çš„ç­–ç•¥ã€‚æœ¬ç»¼è¿°çš„æ–°é¢–ä¹‹å¤„åœ¨äºå…¶åŒé‡è§†è§’ï¼šæè¿°è‚¿ç˜¤å†…åœ¨æ­»äº¡ç¨‹åºå¦‚ä½•é‡æ–°ç¼–ç¨‹è‚¿ç˜¤ TIMEï¼Œä»¥åŠå…ç–«ç»†èƒæ­»äº¡å¦‚ä½•ç›´æ¥å†³å®šå…¶å‘å…ç–«åˆºæ¿€çŠ¶æ€ä¸å…ç–«æŠ‘åˆ¶çŠ¶æ€çš„æåŒ–ï¼Œæœ€ç»ˆå½±å“æ²»ç–—ç»“æœã€‚æˆ‘ä»¬æ·±å…¥åˆ†æäº†ä¸åŒå½¢å¼çš„ RCD å¦‚ä½•å¡‘é€ æŠ—åŸå‘ˆé€’ã€å¼•å¯¼
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://m.x-mol.com/paper/1984490885049131008/t)

**2.** **é‡æ–°æ€è€ƒç°ä»£è‚¿ç˜¤å­¦è¯•éªŒä¸­çš„ç»ˆç‚¹â€”â€”è¶…è¶Š P å€¼ã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šè‚¿ç˜¤
- ğŸ“ **æè¿°**ï¼šSecret hovertext:
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://m.x-mol.com/paper/1984287895235239936/t)

**3.** **é‡æ–°æ€è€ƒç°ä»£è‚¿ç˜¤å­¦è¯•éªŒä¸­çš„ç»ˆç‚¹â€”â€”è¶…è¶Š P å€¼ã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šè‚¿ç˜¤
- ğŸ“ **æè¿°**ï¼šSecret hovertext:
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://m.x-mol.com/paper/1984287899710562304/t)


</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (1æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰

**1.** â­ **Simplifying Interactions with Complex Widgets in shinytest2 Using JavaScript APIs**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šscDNAã€genomeã€genomicsã€epigenetic
- ğŸ“ **æè¿°**ï¼šWhen shinytest2's `set_inputs()` won't work, leverage widget APIs directly. Learn to write cleaner, faster and more robust tests using JavaScript APIs. Continue reading: Simplifying Interactions with Complex Widgets in shinytest2 Using JavaScript APIs
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.r-bloggers.com/2025/10/simplifying-interactions-with-complex-widgets-in-shinytest2-using-javascript-apis/)


</div>

</details>

## ğŸ“Š å…³é”®è¯ç»Ÿè®¡

| å…³é”®è¯ | å‡ºç°æ¬¡æ•° |
|--------|----------|
| è‚¿ç˜¤ | 4 |
| cancer | 4 |
| å•ç»†èƒ | 3 |
| ç™Œç—‡ | 3 |
| scDNA | 3 |
| genome | 3 |
| genomics | 3 |
| scRNA | 2 |
| scATAC | 2 |
| spatial | 2 |
| ç”Ÿä¿¡ | 1 |
| èšç±» | 1 |
| RåŒ… | 1 |
| ç©ºé—´è½¬å½•ç»„ | 1 |
| è½¬å½•ç»„ | 1 |
| epigenetic | 1 |
| Seurat | 1 |
| clustering | 1 |
| Hi-C | 1 |
| single.cell | 1 |

---

*ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-01 21:36*  
*ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ*